Skip to main content

Published locations for MEC plus ixazomib looks promising in relapsed/refractory AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. MEC plus ixazomib looks promising in relapsed/refractory AML

User login

  • Reset your password
  • /content/mec-plus-ixazomib-looks-promising-relapsed/refractory-aml
  • /hematologynews/article/160415/aml/mec-plus-ixazomib-looks-promising-relapsed/refractory-aml
  • /oncologypractice/article/160415/aml/mec-plus-ixazomib-looks-promising-relapsed/refractory-aml
  • /hematology-oncology/article/160415/aml/mec-plus-ixazomib-looks-promising-relapsed/refractory-aml